Evaluation of the risk factors for ventricular arrhythmias secondary to QT prolongation induced by papaverine injection during coronary flow reserve studies using a 4Fr angio-catheter

Evaluation of the risk factors for ventricular arrhythmias secondary to QT prolongation induced by papaverine injection during coronary flow reserve studies using a 4Fr angio-catheter - VA risks of papaverine used FFR

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000031590

Enrollment

200

Registered

2018-03-05

Start date

2016-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ischemic heart disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: iscemic heart disease

Exclusion criteria

Exclusion criteria: renal failure

Design outcomes

Primary

Measure	Time frame
ventricular arrhythmia	—

Countries

Japan

Contacts

Public ContactOkabe Yoshitaka

hospital cardiology

yosi3305@yahoo.co.jp0770223611

Outcome results